Showing 611-620 of 3448 results for "".
What Your Patients Need to Hear About Sunscreens
https://practicaldermatology.com/topics/general-topics/what-your-patients-need-to-hear-about-sunscreens/20432/You can't fight every misperception, but you can arm patients with essential facts.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21062/Vitiligo: Understanding Your Options
https://practicaldermatology.com/youngmd-connect/wrap-ups/vitiligo-understanding-your-options/29890/Showing up is half the battle, it has often been said. According to dermatologist Nanette Silverberg, MD, FAAP, FAAD, chief of pediatric dermatology at Mount Sinai Health System in New York, that adage applied to the attendees at a recent YoungMD Connect virtual session featuring two expert presentaDermatology Q&A: New Directions in the Treatment of Hypopigmented Scars
https://practicaldermatology.com/topics/general-topics/dermatology-qa-new-directions-in-the-treatment-of-hypopigmented-scars/21980/A new study shows that off-label use of an unexpected agent yields promising results in the repigmentation of hypopigmented scars.Diane Thiboutot, MD
https://practicaldermatology.com/topics/general-topics/diane-thiboutot-md/21522/Dermatology Q&A: Treating Melasma and Photoaging Without Hydroquinone
https://practicaldermatology.com/topics/general-topics/dermatology-qa-treating-melasma-and-photoaging-without-hydroquinone/21867/A recently unveiled skin brightening cream may signal a new direction in the treatment and prevention of pigmentation disorders.Ethics and Dermatology: Finding Harmony in Daily Practice
https://practicaldermatology.com/topics/general-topics/PD0109_06-php/22893/While there are no easy resolutions to ethical dilemmas, experts emphasize the importance of reflection and discussion in building higher ethical standards.How Viable is Pay-for-Performance in Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0509_03-php/22825/Though Pay-for-Performance has affected primary care medicine for years, it has only recently expanded into specialized medicine. Experts discuss its eventual impact on dermatology.Phase 2 and 3 Trials of JAK Inhibitors For Atopic Dermatitis: A Review
https://practicaldermatology.com/topics/atopic-dermatitis/phase-2-and-3-trials-of-jak-inhibitors-for-atopic-dermatitis-a-review/23265/A number of drugs in development show promise for one of the most challening skin diseases.Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.